Patents by Inventor Makoto Yagi
Makoto Yagi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240154446Abstract: In an electric power device and a method for controlling the same, a first circuit is electrically connected to a first battery tray and a second battery tray, a second circuit is electrically connected to the first battery tray, and a third circuit is electrically connected to the second battery tray. Between the first circuit and the second circuit, a first resistor unit is connected in series with the first battery tray, and a first interrupting unit is connected in parallel with the first resistor unit. Between the first circuit and the third circuit, a second resistor unit is connected in series with the second battery tray, and a second interrupting unit is connected in parallel with the second resistor unit.Type: ApplicationFiled: March 9, 2022Publication date: May 9, 2024Inventors: Atsushi Nakajima, Satoshi Odakura, Keita Yagi, Takumi Shiiyama, Tatsuya Uchimoto, Makoto Ogawa, Koichiro Takemasa, Hiroshi Miyazaki
-
Patent number: 8548182Abstract: This auxiliary member for a hearing aid comprises a main body case (1) having an insertion hole (3) of a hearing aid (2) on a top face, a hearing aid accommodating space (1A) provided to the portion corresponding to the insertion hole (3) inside this main body case (1), a holding member (15) that holds the hearing aid (2) accommodated in this hearing aid accommodating space (1A), a manipulation component (11) for manipulating this holding member (15), and an opening component (16) for opening a battery case (5) of the hearing aid (2) accommodated in the hearing aid accommodating space (1A).Type: GrantFiled: May 23, 2011Date of Patent: October 1, 2013Assignee: Panasonic CorporationInventors: Shinichi Yasui, Makoto Yagi
-
Patent number: 8345905Abstract: An arc-shaped waterproof wall is provided around a shaft to which a hearing aid main body case and a battery case are rotatably attached, and waterproof ribs are provided to the outer periphery of the installation face of the battery case and the hearing aid main body case, which improves the ability to prevent the penetration of moisture while also keep the cost low.Type: GrantFiled: March 8, 2010Date of Patent: January 1, 2013Assignee: Panasonic CorporationInventors: Keiichi Takeda, Yosimasa Simogochi, Minoru Tada, Makoto Yagi, Fumihiro Asayama
-
Patent number: 8270645Abstract: A hearing aid includes a main body and a battery holder that can be opened and closed with respect to the main body by revolving around a revolving shaft. The main body has a lock bar provided so as to traverse the space in which the battery holder is installed, and a protruding portion that protrudes toward this installation space. The battery holder has a first concave portion and a second concave portion that latch the lock bar and the protruding portion.Type: GrantFiled: March 8, 2010Date of Patent: September 18, 2012Assignee: Panasonic CorporationInventors: Keiichi Takeda, Yosimasa Simogochi, Minoru Tada, Makoto Yagi, Fumihiro Asayama
-
Publication number: 20120039498Abstract: This auxiliary member for a hearing aid comprises a main body case (1) having an insertion hole (3) of a hearing aid (2) on a top face, a hearing aid accommodating space (1A) provided to the portion corresponding to the insertion hole (3) inside this main body case (1), a holding member (15) that holds the hearing aid (2) accommodated in this hearing aid accommodating space (1A), a manipulation component (11) for manipulating this holding member (15), and an opening component (16) for opening a battery case (5) of the hearing aid (2) accommodated in the hearing aid accommodating space (1A).Type: ApplicationFiled: May 23, 2011Publication date: February 16, 2012Inventors: Shinichi Yasui, Makoto Yagi
-
Publication number: 20110269960Abstract: An object of the present invention is to provide a compound having an action of inhibiting binding between S1P and its receptor, Edg-1 (S1P1), and is useful as a pharmaceutical compound. A compound or a pharmaceutically acceptable salt thereof, which compound is represented by the formula below (where A represents an oxygen atom, a sulfur atom, a group represented by Formula —SO—, a group represented by Formula —SO2—, or the like, R1 represents a hydrogen atom, an alkyl group having 1-6 carbon atoms, or the like, R1A represents a hydrogen atom or the like, R2 represents an alkyl group having 1-6 carbon atoms, a cycloalkyl group having 3-6 carbon atoms, or the like, R3 represents an aryl group, R4 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms and optionally substituted with a carboxyl group, and R5 represents an alkyl group having 1-10 carbon atoms, a cycloalkyl group having 3-8 carbon atoms, an aryl group which is optionally substituted, or the like).Type: ApplicationFiled: July 11, 2011Publication date: November 3, 2011Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Naoya ONO, Tetsuo Takayama, Fumiyasu Shiozawa, Hironori Katakai, Tetsuya Yabuuchi, Tomomi Ota, Makoto Yagi, Masakazu Sato
-
Patent number: 8022225Abstract: A compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof has an effect of inhibiting binding between S1P and its receptor Edg-1(S1P1), and is useful as a pharmaceutical product. [where A represents a sulfur atom, an oxygen atom, a formula —SO— or a formula —SO2—; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or the like; R2 represents an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms or the like; R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a phenyl group or the like; R5 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R6 represents an alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group].Type: GrantFiled: August 4, 2005Date of Patent: September 20, 2011Assignee: Taisho Pharmaceutical Co., LtdInventors: Naoya Ono, Masakazu Sato, Fumiyasu Shiozawa, Makoto Yagi, Tetsuya Yabuuchi, Tetsuo Takayama, Hironori Katakai
-
Patent number: 8022091Abstract: An object of the present invention is to provide a compound having an action of inhibiting binding between S1P and its receptor, Edg-1 (S1P1), and is useful as a pharmaceutical compound. A compound or a pharmaceutically acceptable salt thereof, which compound is represented by the formula below (where A represents an oxygen atom, a sulfur atom, a group represented by Formula —SO—, a group represented by Formula —SO2—, or the like, R1 represents a hydrogen atom, an alkyl group having 1-6 carbon atoms, or the like, R1A represents a hydrogen atom or the like, R2 represents an alkyl group having 1-6 carbon atoms, a cycloalkyl group having 3-6 carbon atoms, or the like, R3 represents an aryl group, R4 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms and optionally substituted with a carboxyl group, and R5 represents an alkyl group having 1-10 carbon atoms, a cycloalkyl group having 3-8 carbon atoms, an aryl group which is optionally substituted, or the like).Type: GrantFiled: February 5, 2007Date of Patent: September 20, 2011Assignee: Taisho Pharmaceutical Co., Ltd.Inventors: Naoya Ono, Tetsuo Takayama, Fumiyasu Shiozawa, Hironori Katakai, Tetsuya Yabuuchi, Tomomi Ota, Makoto Yagi, Masakazu Sato
-
Publication number: 20110013795Abstract: An arc-shaped waterproof wall is provided around a shaft to which a hearing aid main body case and a battery case are rotatably attached, and waterproof ribs are provided to the outer periphery of the installation face of the battery case and the hearing aid main body case, which improves the ability to prevent the penetration of moisture while also keep the cost low.Type: ApplicationFiled: March 8, 2010Publication date: January 20, 2011Inventors: Keiichi Takeda, Yosimasa Simogochi, Minoru Tada, Makoto Yagi, Fumihiro Asayama
-
Publication number: 20100298557Abstract: Disclosed is a novel compound having Syk and/or Abl inhibitory activities, which is useful for prevention/treatment of allergic diseases, autoimmune diseases, arthritides and cancers. Specifically disclosed is a pyrazolopyrimidine compound represented by the formula [I] or [III] below, a tautomer thereof, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvent of any of them.Type: ApplicationFiled: December 28, 2007Publication date: November 25, 2010Applicant: Taisho Pharmaceutical Co., LtdInventors: Makoto Yagi, Hiroki Umemiya, Hajime Asanuma, Yusuke Oka, Rie Nishikawa, Keisi Hayashi, Takumi Okada, Takanori Shimizu, Shigetada Sasako
-
Publication number: 20100290655Abstract: A hearing aid (100) comprises a main body (10) and a battery holder (50) that can be opened and closed with respect to the main body by revolving around a revolving shaft. The main body (10) has a lock bar (12) provided so as to traverse the space in which the battery holder (50) is installed, and a protruding portion (14) that protrudes toward this installation space. The battery holder (50) has a first concave portion (62) and a second concave portion (64) that latch the lock bar and the protruding portion.Type: ApplicationFiled: March 8, 2010Publication date: November 18, 2010Inventors: Keiichi Takeda, Yosimasa Simogochi, Minoru Tada, Makoto Yagi, Fumihiro Asayama
-
Patent number: 7763652Abstract: A prostaglandin derivative represented by Formula (I): wherein X is a halogen atom in the ?- or ?-substitution, Y is an ethylene group, a vinylene group or an ethynylene group, R1 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with a C1-4 straight or branched chain alkyl group or a C4-13 cycloalkylalkyl group, R2 is a hydrogen atom or a CO2R3 group (R3 is a hydrogen atom, a C1-4 straight or branched chain alkyl group or a C2-4 straight or branched chain alkenyl group), n is an integer of 1 to 4 and p is 0, 1 or 2, a pharmaceutically acceptable salt thereof or a hydrate thereof.Type: GrantFiled: July 11, 2003Date of Patent: July 27, 2010Assignees: Taisho Pharmaceutical Co., Ltd.Inventors: Fumie Sato, Tohru Tanami, Makoto Yagi, Naoya Ono
-
Patent number: 7718701Abstract: A method of treating atopy-evoked pruritic symptoms by administering a prostaglandin derivative.Type: GrantFiled: August 7, 2003Date of Patent: May 18, 2010Assignees: Taisho Pharmaceutical Co., Ltd., Fumi SatoInventors: Fumie Sato, Iwao Arai, Norikazu Takano, Tohru Tanami, Makoto Yagi
-
Publication number: 20100041655Abstract: An object of the present invention is to provide a compound having an action of inhibiting binding between S1P and its receptor, Edg-1 (S1P1), and is useful as a pharmaceutical compound. A compound or a pharmaceutically acceptable salt thereof, which compound is represented by the formula below (where A represents an oxygen atom, a sulfur atom, a group represented by Formula —SO—, a group represented by Formula —SO2— or the like, R1 represents a hydrogen atom, an alkyl group having 1-6 carbon atoms, or the like, R1A represents a hydrogen atom or the like, R2 represents an alkyl group having 1-6 carbon atoms, a cycloalkyl group having 3-6 carbon atoms, or the like, represents an aryl group, R4 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms and optionally substituted with a carboxyl group, and R5 represents an alkyl group having 1-carbon atoms, a cycloalkyl group having 3-8 carbon atoms, an aryl group which is optionally substituted, or the like).Type: ApplicationFiled: February 5, 2007Publication date: February 18, 2010Inventors: Naoya Ono, Tetsuo Takayama, Fumiyasu Shiozawa, Hironori Katakai, Tetsuya Yabuuchi, Tomomi Ota, Makoto Yagi, Masakazu Sato
-
Publication number: 20090131438Abstract: A compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof has an effect of inhibiting binding between S1P and its receptor Edg-1(S1P1), and is useful as a pharmaceutical product. [where A represents a sulfur atom, an oxygen atom, a formula —SO— or a formula —SO2—; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or the like; R2 represents an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms or the like; R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a phenyl group or the like; R5 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R6 represents an alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group].Type: ApplicationFiled: August 4, 2005Publication date: May 21, 2009Applicant: Taisho Pharmaceutical Co., LtdInventors: Naoya Ono, Masakazu Sato, Fumiyasu Shiozawa, Makoto Yagi, Tetsuya Yabuuchi, Tetsuo Takayama, Hironori Katakai
-
Publication number: 20060270740Abstract: A prostaglandin derivative represented by the formula (wherein X is a halogen atom; Y is ethylene group, vinylene group or ethylylene group; Z is a group represented by —(CH2)m, —O(CH2)n— or —S(O)p—(CH2)n— (m is an integer of 0 to 3; n is an integer of 0 to 2; and p is an integer of 0 to 2); R1 is a hydrogen atom, a C1-5 alkyl group or a substituted C1-5 alkyl group; R2 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted by C1-4 alkyl group or C4-15 cycloalkylalkyl group; and R3 is a hydrogen atom, a halogen atom or a C1-5 alkyl group or a substituted C1-5 alkyl group), a pharmaceutically acceptable salt thereof or a hydrate thereof which has an excellent antagonism to prostaglandin DP receptor and, therefore, is useful against diseases such as allergic rhinitis, nasal obstruction, asthma, allergic conjunctivitis, systemic mastocytosis and disorder of systemic mast cell activation.Type: ApplicationFiled: February 19, 2004Publication date: November 30, 2006Inventors: Fumie Sato, Tohru Tanami, Naoya Ono, Makoto Yagi, Takayuki Seki, Mariko Sato
-
Publication number: 20060094788Abstract: A prostaglandin derivative represented by Formula (I): wherein X is a halogen atom in the ?- or ?-substitution, Y is an ethylene group, a vinylene group or an ethynylene group, R1 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with a C1-4 straight or branched chain alkyl group or a C4-13 cycloalkylalkyl group, R2 is a hydrogen atom or a CO2R3 group (R3 is a hydrogen atom, a C1-4 straight or branched chain alkyl group or a C2-4 straight or branched chain alkenyl group), n is an integer of 1 to 4 and p is 0, 1 or 2, a pharmaceutically acceptable salt thereof or a hydrate thereof.Type: ApplicationFiled: July 11, 2003Publication date: May 4, 2006Inventors: Fumie Sato, Tohru Tanami, Makoto Yagi, Naoya Ono
-
Publication number: 20050009917Abstract: A pharmaceutical preparation for preventing or treating pruritic symptoms which contains as an effective ingredient a prostaglandin derivative represented by formula [1] wherein X1 and X2 which are different from each other represent a hydrogen atom, a halogen atom or a hydroxyl group; Y is an ethylene group, a vinylene group or an ethynylene group; Z is the formula (CH2)kA(CH2)hB(CH2)q, (CH2)kA(CH2)rA?(CH2)t (CH2)kB(CH2)hB?(CH2)q or (CH2)k-1B?(CH2)q-1A? wherein k is an integer of 1 to 4, h is an integer of 0 to 4, q is an integer 1 to 4, r is an integer of 0 to 4, and t is an integer of 0 to 2; A and A? which may be the same or different represent an ethylene group, a vinylene group or an ethynylene group; B and B? which may be the same or different represent an oxygen atom or a group represented by the formula S(O)u wherein u is an integer of 0 to 2; W1 is a hydroxyl group, a C1-10 alkyloxy group, a C3-10 cycloalkyloxy group, an aryloxy group or an arylalkyloxy group; W2 is a C1-10 alkyl grouType: ApplicationFiled: August 7, 2003Publication date: January 13, 2005Inventors: Fumie Sato, Iwai Arai, Norikazu Takano, Tohru Tanami, Makoto Yagi
-
Publication number: 20040266880Abstract: The pharmaceutical preparation of the invention, which comprises a prostaglandin or a pharmaceutically acceptable salt thereof as an effective ingredient, has an antipruritic effect with fewer side effects. It is particularly effective in controlling the itch sensation accompanying atopic symptoms.Type: ApplicationFiled: April 19, 2004Publication date: December 30, 2004Inventors: Fumie Sato, Iwao Arai, Norikazu Takano, Tohru Tanami, Makoto Yagi
-
Patent number: 6822112Abstract: A prostaglandin derivative represented by the formula: wherein X is a halogen atom, R1 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, m is an integer of 0 to 5, and Y is a group represented by the formula: wherein R2 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with C1-4 alkyl group(s), a C1-4 alkyl group substituted with C3-10 cycloalkyl group(s), a C1-10 alkyl group, a C2-10 alkenyl group, a C2-10 alkynyl group or a bridged cyclic hydrocarbon group, or a group represented by the formula: wherein n is an integer of 1 to 8; a pharmaceutically acceptable salt thereof or a hydrate thereof.Type: GrantFiled: February 5, 2002Date of Patent: November 23, 2004Assignees: Taisho Pharmaceutical Co., Ltd.Inventors: Fumie Sato, Tohru Tanami, Hideo Tanaka, Naoya Ono, Makoto Yagi